Xention Xention specializes in the discovery and development of orally bioavailable, small molecule ion channel modulators. Over the last decade, the company has accumulated extensive capabilities in ion channel drug discovery, with its core disciplines being electrophysiology-based compound screening and ion channel medicinal chemistry. Xention’s scientists have worked on a wide range of ion channel targets, across a number of therapeutic areas, and have demonstrated the ability to generate potent and selective development candidates.   Through the utilization of our comprehensive research platform, we aim to continue delivering high quality development candidates with partners that share our interest in ion channels as targets. Therefore, we are interested in hearing from pharmaceutical and biotechnology companies that are searching for ion channel drug discovery services.